DORZOLAMIDE

DORZOLAMIDE was reported 7988 times

DORZOLAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL VAS DEFERENS ABSENCE 13 0.6500
1 CONGENITAL MUSCLE ABSENCE 13 0.3333
2 STEROID DEPENDENCE 145 0.1651
3 CATARRH 146 0.1615
4 CONJUNCTIVAL FOLLICLES 4 0.1250
5 BURNS SECOND DEGREE 149 0.0849
6 OCULAR SURFACE DISEASE 21 0.0747
7 EYELID CONTUSION 4 0.0597
8 CONJUNCTIVAL EROSION 6 0.0496
9 CONJUNCTIVAL SCAR 7 0.0464
10 HYPOPNOEA 148 0.0426
11 ANTERIOR CHAMBER DISORDER 9 0.0391
12 OPEN ANGLE GLAUCOMA 24 0.0391
13 ALCOHOL POISONING 100 0.0373
14 CHOROIDAL DETACHMENT 20 0.0360
15 SINGLE UMBILICAL ARTERY 13 0.0352
16 HYPHAEMA 18 0.0345
17 HYPOTONY OF EYE 14 0.0333
18 GLAUCOMA SURGERY 8 0.0312
19 CHOROIDAL EFFUSION 25 0.0311
20 CORNEAL DECOMPENSATION 5 0.0311
21 INSTILLATION SITE DRYNESS 4 0.0310
22 CORNEAL GRAFT REJECTION 6 0.0286
23 FLAT ANTERIOR CHAMBER OF EYE 5 0.0279
24 CHOROIDAL HAEMORRHAGE 5 0.0259
25 PRODUCT DROPPER ISSUE 20 0.0254
26 BRONCHIECTASIS 153 0.0227
27 PERIORBITAL INFLAMMATION 5 0.0216
28 OCULAR PROCEDURAL COMPLICATION 4 0.0206
29 CORNEAL NEOVASCULARISATION 5 0.0202
30 PAROSMIA 148 0.0196
31 GINGIVAL PAIN 156 0.0196
32 FLOPPY IRIS SYNDROME 7 0.0190
33 RHINITIS 152 0.0188
34 EYE COMPLICATION ASSOCIATED WITH DEVICE 5 0.0186
35 INSTILLATION SITE PRURITUS 7 0.0186
36 ATOPY 5 0.0180
37 ECTROPION 6 0.0178
38 INTRAOCULAR PRESSURE INCREASED 221 0.0173
39 CARDIAC MURMUR 149 0.0172
40 TREATMENT FAILURE 1371 0.0165
41 PULMONARY HYPOPLASIA 13 0.0165
42 PERIORBITAL PAIN 12 0.0142
43 INTRAOCULAR LENS IMPLANT 7 0.0141
44 CORNEAL OEDEMA 31 0.0138
45 OCULAR HYPERTENSION 26 0.0134
46 INTRAOCULAR PRESSURE DECREASED 7 0.0133
47 JOINT CONTRACTURE 14 0.0130
48 INTRAOCULAR PRESSURE TEST ABNORMAL 9 0.0128
49 EYELID PAIN 25 0.0123
50 CORNEAL DYSTROPHY 5 0.0120
51 ABDOMINAL LYMPHADENOPATHY 10 0.0115
52 CORNEAL TRANSPLANT 9 0.0115
53 INSTILLATION SITE ERYTHEMA 6 0.0114
54 CORNEAL PERFORATION 7 0.0111
55 RETINAL VASCULAR OCCLUSION 8 0.0108
56 CORNEAL DEPOSITS 8 0.0108
57 MEAN PLATELET VOLUME DECREASED 9 0.0107
58 CARDIOACTIVE DRUG LEVEL INCREASED 14 0.0106
59 CONJUNCTIVAL DISORDER 4 0.0105
60 ENDOCRINE OPHTHALMOPATHY 9 0.0104
61 GENITAL ERYTHEMA 5 0.0101
62 GLAUCOMA 190 0.0099
63 IMPAIRED QUALITY OF LIFE 141 0.0098
64 THYROXINE DECREASED 6 0.0097
65 CYSTOID MACULAR OEDEMA 18 0.0095
66 CONJUNCTIVAL HYPERAEMIA 33 0.0092
67 GINGIVAL BLISTER 4 0.0092
68 VISUAL ACUITY TESTS ABNORMAL 5 0.0090
69 GROWTH OF EYELASHES 7 0.0088
70 AORTIC CALCIFICATION 5 0.0086
71 EYE BURNS 5 0.0085
72 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
73 HYPOAESTHESIA EYE 5 0.0085
74 EYE LASER SURGERY 5 0.0084
75 SUPERFICIAL INJURY OF EYE 9 0.0082
76 IRIDOCYCLITIS 26 0.0082
77 CATARACT SUBCAPSULAR 5 0.0082
78 RETINAL ISCHAEMIA 5 0.0082
79 TUBULOINTERSTITIAL NEPHRITIS 149 0.0079
80 PRODUCT CONTAINER ISSUE 67 0.0078
81 BLEPHARITIS 31 0.0077
82 INJURY CORNEAL 4 0.0077
83 ULCERATIVE KERATITIS 21 0.0077
84 INSTILLATION SITE IRRITATION 9 0.0076
85 MONOCYTE COUNT DECREASED 9 0.0074
86 REACTION TO PRESERVATIVES 6 0.0074
87 TUMOUR FLARE 5 0.0073
88 EYELID MARGIN CRUSTING 21 0.0073
89 BURN ORAL CAVITY 4 0.0069
90 IMPAIRED WORK ABILITY 148 0.0069
91 ANTERIOR CHAMBER INFLAMMATION 4 0.0067
92 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11 0.0066
93 ARTERITIS 4 0.0063
94 FOREIGN BODY SENSATION IN EYES 39 0.0061
95 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 5 0.0061
96 FREQUENT BOWEL MOVEMENTS 164 0.0061
97 SCLERAL HYPERAEMIA 4 0.0059
98 ANGLE CLOSURE GLAUCOMA 15 0.0059
99 CONJUNCTIVAL OEDEMA 6 0.0058
100 EYE PAIN 327 0.0058
101 LEIOMYOMA 4 0.0057
102 INSTILLATION SITE PAIN 14 0.0056
103 ANTERIOR CHAMBER CELL 4 0.0056
104 PRODUCT DESIGN ISSUE 4 0.0056
105 PLEUROTHOTONUS 5 0.0055
106 EYE IRRITATION 316 0.0055
107 FOREIGN BODY IN EYE 5 0.0052
108 SWOLLEN TONGUE 162 0.0052
109 VITREOUS HAEMORRHAGE 14 0.0051
110 NEPHROGENIC ANAEMIA 23 0.0050
111 PRODUCT CLOSURE REMOVAL DIFFICULT 5 0.0049
112 ERYTHEMA OF EYELID 26 0.0048
113 HYPERPARATHYROIDISM SECONDARY 12 0.0048
114 EYELID IRRITATION 12 0.0048
115 SWELLING OF EYELID 30 0.0048
116 OCULAR DISCOMFORT 53 0.0047
117 EYE INFLAMMATION 45 0.0047
118 NIGHTMARE 161 0.0046
119 RETINAL DISORDER 12 0.0046
120 IRITIS 14 0.0046
121 ACCIDENTAL OVERDOSE 167 0.0046
122 ACUTE CHEST SYNDROME 4 0.0046
123 PRODUCT DEPOSIT 7 0.0045
124 PRODUCT DELIVERY MECHANISM ISSUE 24 0.0045
125 VITRITIS 8 0.0043
126 SYSTEMIC LUPUS ERYTHEMATOSUS 151 0.0043
127 OPTIC NEUROPATHY 9 0.0042
128 LABILE BLOOD PRESSURE 5 0.0042
129 OLIGOHYDRAMNIOS 14 0.0042
130 PRODUCT AFTER TASTE 4 0.0042
131 RETINAL OEDEMA 8 0.0042
132 ORAL MUCOSA EROSION 5 0.0041
133 CONJUNCTIVITIS ALLERGIC 6 0.0040
134 PRODUCT CONTAINER SEAL ISSUE 7 0.0040
135 RECTAL HAEMORRHAGE 172 0.0040
136 ASTIGMATISM 6 0.0040
137 BLOOD PRESSURE DIASTOLIC ABNORMAL 10 0.0039
138 OCULAR HYPERAEMIA 186 0.0039
139 DAYDREAMING 6 0.0039
140 BLINDNESS UNILATERAL 54 0.0038
141 METAMORPHOPSIA 7 0.0038
142 EYE DISCHARGE 39 0.0037
143 STARING 9 0.0037
144 TINNITUS 169 0.0037
145 CORNEAL OPACITY 5 0.0037
146 INTESTINAL POLYP 6 0.0036
147 CORNEAL DISORDER 8 0.0036
148 HYPERAEMIA 7 0.0035
149 EYE OPERATION 16 0.0035
150 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 166 0.0035
151 OPTIC NERVE INJURY 4 0.0034
152 COLITIS ULCERATIVE 153 0.0034
153 VISUAL FIELD DEFECT 24 0.0033
154 REBOUND ACID HYPERSECRETION 10 0.0033
155 HYPERSEXUALITY 6 0.0033
156 PHOTOPHOBIA 61 0.0032
157 EYE PRURITUS 108 0.0032
158 EYELIDS PRURITUS 10 0.0032
159 INCORRECT DOSE ADMINISTERED BY PRODUCT 5 0.0031
160 RENAL COLIC 7 0.0031
161 ECZEMA 160 0.0031
162 MACULAR OEDEMA 17 0.0030
163 HAEMATOCHEZIA 165 0.0030
164 EYE INJURY 9 0.0030
165 KERATITIS 9 0.0030
166 LACRIMATION INCREASED 88 0.0029
167 CONJUNCTIVAL HAEMORRHAGE 11 0.0029
168 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 4 0.0029
169 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
170 VERTIGO 171 0.0028
171 MEDICATION ERROR 154 0.0028
172 UVEITIS 37 0.0027
173 CLOSTRIDIUM TEST POSITIVE 6 0.0027
174 RED CELL DISTRIBUTION WIDTH INCREASED 11 0.0026
175 EYE ALLERGY 4 0.0026
176 EYE INFECTION 29 0.0026
177 ABNORMAL SENSATION IN EYE 11 0.0026
178 DEEP VEIN THROMBOSIS 165 0.0025
179 KERATOPATHY 4 0.0025
180 CATARACT OPERATION 15 0.0025
181 DYSGEUSIA 187 0.0025
182 SCLERITIS 4 0.0025
183 PERIORBITAL SWELLING 14 0.0025
184 VASCULAR OCCLUSION 5 0.0024
185 VITREOUS FLOATERS 23 0.0023
186 MEDICAL DEVICE REMOVAL 4 0.0023
187 MICTURITION DISORDER 8 0.0023
188 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
189 ARTHRITIS 179 0.0023
190 INFUSION SITE PRURITUS 7 0.0022
191 VISUAL ACUITY REDUCED 73 0.0022
192 SCIATICA 35 0.0022
193 SUSPECTED PRODUCT QUALITY ISSUE 4 0.0022
194 EYELID DISORDER 5 0.0022
195 PRODUCT USE COMPLAINT 34 0.0022
196 COLITIS MICROSCOPIC 10 0.0021
197 VOLVULUS 5 0.0021
198 DUODENAL ULCER HAEMORRHAGE 6 0.0021
199 OXYGEN CONSUMPTION INCREASED 5 0.0021
200 POTENTIATING DRUG INTERACTION 7 0.0021
201 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
202 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
203 LIQUID PRODUCT PHYSICAL ISSUE 15 0.0021
204 DERMAL CYST 5 0.0020
205 RETINAL TEAR 5 0.0020
206 INTENTIONAL PRODUCT USE ISSUE 177 0.0020
207 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
208 ENDOPHTHALMITIS 12 0.0020
209 EYE SWELLING 74 0.0020
210 RETINAL ARTERY OCCLUSION 5 0.0020
211 ACTINIC KERATOSIS 5 0.0019
212 HAND DEFORMITY 25 0.0019
213 INFUSION SITE BRUISING 4 0.0019
214 HORDEOLUM 8 0.0018
215 PERIODONTITIS 4 0.0018
216 ASTHENOPIA 10 0.0018
217 BLINDNESS 74 0.0018
218 SKIN INJURY 6 0.0018
219 CONJUNCTIVITIS 33 0.0018
220 BLOOD LOSS ANAEMIA 4 0.0018
221 MIGRAINE 168 0.0018
222 CATARACT 104 0.0017
223 VISION BLURRED 239 0.0017
224 PHOTOPSIA 11 0.0017
225 RETINAL VEIN OCCLUSION 5 0.0017
226 EYE DISORDER 57 0.0017
227 HYPERTONIC BLADDER 5 0.0017
228 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
229 PULMONARY EMBOLISM 164 0.0017
230 URINE OUTPUT DECREASED 15 0.0017
231 DRY EYE 85 0.0017
232 BONE EROSION 6 0.0017
233 SKIN ABRASION 8 0.0017
234 INFUSION SITE REACTION 5 0.0017
235 PALPITATIONS 196 0.0017
236 ADVERSE DRUG REACTION 147 0.0016
237 RETINAL DETACHMENT 15 0.0016
238 EYE OEDEMA 4 0.0016
239 BLINDNESS TRANSIENT 12 0.0016
240 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
241 RETINOPATHY 6 0.0016
242 HAEMORRHAGE URINARY TRACT 4 0.0016
243 HEPATIC CYTOLYSIS 20 0.0016
244 CONFUSIONAL STATE 250 0.0015
245 PERIORBITAL OEDEMA 8 0.0015
246 VISUAL IMPAIRMENT 190 0.0015
247 HYPERSENSITIVITY 283 0.0015
248 DEAFNESS NEUROSENSORY 5 0.0015
249 DIABETIC RETINOPATHY 5 0.0015
250 MIGRAINE WITH AURA 4 0.0015
251 EYE MOVEMENT DISORDER 10 0.0015
252 HYPERKERATOSIS 8 0.0014
253 INFUSION SITE SWELLING 9 0.0014
254 END STAGE RENAL DISEASE 26 0.0014
255 SKIN HYPERTROPHY 4 0.0014
256 HYPERVOLAEMIA 7 0.0014
257 SEASONAL ALLERGY 20 0.0014
258 BLOOD MAGNESIUM DECREASED 12 0.0014
259 DRY THROAT 14 0.0014
260 PRODUCT COLOUR ISSUE 7 0.0014
261 METABOLIC ENCEPHALOPATHY 4 0.0013
262 PLATELET COUNT INCREASED 17 0.0013
263 ABDOMINAL DISCOMFORT 218 0.0013
264 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 233 0.0013
265 SKIN LACERATION 14 0.0013
266 ORAL INFECTION 5 0.0013
267 FOREIGN BODY IN THROAT 4 0.0013
268 HAEMATOCRIT DECREASED 25 0.0013
269 SPINAL FUSION SURGERY 5 0.0012
270 UTERINE LEIOMYOMA 9 0.0012
271 GRANULOCYTOPENIA 7 0.0012
272 PSYCHIATRIC SYMPTOM 9 0.0012
273 METABOLIC DISORDER 7 0.0012
274 COVID-19 209 0.0012
275 INFUSION SITE ERYTHEMA 10 0.0012
276 POOR PERIPHERAL CIRCULATION 5 0.0012
277 EAR PRURITUS 4 0.0011
278 HALLUCINATION, VISUAL 24 0.0011
279 HEAD DISCOMFORT 20 0.0011
280 CEREBROVASCULAR ACCIDENT 191 0.0011
281 GLOSSITIS 4 0.0011
282 MIOSIS 9 0.0011
283 FACIAL PAIN 10 0.0011
284 NASAL DRYNESS 7 0.0011
285 PRODUCT RESIDUE PRESENT 6 0.0011
286 BLADDER DISORDER 11 0.0011
287 SOMNOLENCE 223 0.0011
288 NONSPECIFIC REACTION 6 0.0011
289 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
290 BLOOD PRESSURE FLUCTUATION 26 0.0011
291 FREEZING PHENOMENON 4 0.0011
292 PRODUCT DISTRIBUTION ISSUE 10 0.0011
293 CARDIAC DYSFUNCTION 4 0.0011
294 NEUTROPHIL COUNT INCREASED 11 0.0011
295 ROSACEA 5 0.0011
296 NOCTURIA 13 0.0011
297 DEFORMITY 10 0.0011
298 PRODUCT LEAKAGE 6 0.0011
299 CHRONIC SINUSITIS 4 0.0011
300 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
301 EYE HAEMORRHAGE 14 0.0010
302 SKIN HYPERPIGMENTATION 9 0.0010
303 POOR QUALITY PRODUCT ADMINISTERED 11 0.0010
304 OESOPHAGEAL ULCER 4 0.0010
305 BLOOD URIC ACID INCREASED 6 0.0010
306 PRODUCT ADMINISTRATION ERROR 21 0.0010
307 ONYCHOCLASIS 7 0.0010
308 BRADYKINESIA 6 0.0010
309 RESPIRATION ABNORMAL 7 0.0010
310 ISCHAEMIC STROKE 18 0.0010
311 OESOPHAGITIS 11 0.0010
312 ANAL INCONTINENCE 9 0.0010
313 PRODUCT USE IN UNAPPROVED INDICATION 247 0.0010
314 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
315 NEUTROPENIC SEPSIS 7 0.0010
316 IMPAIRED DRIVING ABILITY 11 0.0010
317 FAECES SOFT 7 0.0010
318 BRADYCARDIA 51 0.0010
319 WEIGHT DECREASED 266 0.0010
320 GASTRITIS 25 0.0009
321 DEPRESSION 216 0.0009
322 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
323 CHOLESTASIS 18 0.0009
324 PAIN IN EXTREMITY 276 0.0009
325 C-REACTIVE PROTEIN ABNORMAL 6 0.0009
326 PRODUCT DISPENSING ISSUE 4 0.0009
327 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
328 MUSCULOSKELETAL DISCOMFORT 16 0.0009
329 PSYCHOLOGICAL TRAUMA 8 0.0009
330 HIP SURGERY 5 0.0009
331 PRODUCT AVAILABILITY ISSUE 21 0.0009
332 MACULAR DEGENERATION 11 0.0009
333 FAECALOMA 5 0.0009
334 HOSPICE CARE 9 0.0009
335 CHRONIC KIDNEY DISEASE 69 0.0009
336 HYPERSOMNIA 26 0.0009
337 APPETITE DISORDER 6 0.0009
338 PHYSICAL DISABILITY 4 0.0009
339 CONCUSSION 7 0.0009
340 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
341 PELVIC FRACTURE 7 0.0009
342 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
343 ARTERIAL OCCLUSIVE DISEASE 7 0.0009
344 IRON DEFICIENCY 4 0.0009
345 PAPILLOEDEMA 4 0.0009
346 OROPHARYNGEAL DISCOMFORT 8 0.0009
347 CONDITION AGGRAVATED 269 0.0009
348 PRODUCT LABEL ISSUE 6 0.0009
349 SECRETION DISCHARGE 11 0.0009
350 RED BLOOD CELL COUNT DECREASED 25 0.0009
351 EAR DISORDER 4 0.0009
352 PROSTATIC SPECIFIC ANTIGEN INCREASED 12 0.0009
353 HAIR GROWTH ABNORMAL 6 0.0009
354 MOUTH SWELLING 5 0.0009
355 MUSCLE DISORDER 7 0.0009
356 MADAROSIS 10 0.0009
357 OSTEOPENIA 13 0.0009
358 PRESCRIBED UNDERDOSE 17 0.0009
359 FULL BLOOD COUNT ABNORMAL 9 0.0009
360 ARTERIOSCLEROSIS 8 0.0008
361 THYROID DISORDER 13 0.0008
362 RETINAL HAEMORRHAGE 6 0.0008
363 AGEUSIA 21 0.0008
364 RECALLED PRODUCT ADMINISTERED 8 0.0008
365 CARDIAC PACEMAKER INSERTION 5 0.0008
366 DELUSION 13 0.0008
367 HALLUCINATION 63 0.0008
368 POLYNEUROPATHY 10 0.0008
369 ABNORMAL DREAMS 23 0.0008
370 SENSATION OF FOREIGN BODY 7 0.0008
371 RIB FRACTURE 17 0.0008
372 PULMONARY THROMBOSIS 9 0.0008
373 DYSPNOEA EXERTIONAL 31 0.0008
374 VITAMIN D DECREASED 7 0.0008
375 INCORRECT DOSAGE ADMINISTERED 4 0.0008
376 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
377 MUSCLE STRAIN 7 0.0008
378 INTENTIONAL DOSE OMISSION 23 0.0008
379 PRODUCTIVE COUGH 38 0.0008
380 LOCALISED INFECTION 19 0.0008
381 ARRHYTHMIA 37 0.0008
382 GAIT INABILITY 26 0.0008
383 PROCTALGIA 5 0.0008
384 ACUTE KIDNEY INJURY 119 0.0008
385 HYPOALBUMINAEMIA 6 0.0008
386 DIPLOPIA 20 0.0008
387 DYSPHONIA 45 0.0008
388 BRADYPHRENIA 5 0.0008
389 HYPOGLYCAEMIA 37 0.0008
390 NASAL DISCOMFORT 6 0.0008
391 HAIR TEXTURE ABNORMAL 10 0.0007
392 COMPRESSION FRACTURE 4 0.0007
393 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
394 FULL BLOOD COUNT DECREASED 15 0.0007
395 FRUSTRATION TOLERANCE DECREASED 6 0.0007
396 TASTE DISORDER 15 0.0007
397 PULMONARY MASS 11 0.0007
398 PRODUCT PACKAGING ISSUE 7 0.0007
399 HAEMORRHAGE INTRACRANIAL 11 0.0007
400 SYNOVITIS 13 0.0007
401 FEELING COLD 20 0.0007
402 DEMENTIA 20 0.0007
403 RIGHT VENTRICULAR FAILURE 5 0.0007
404 SNEEZING 16 0.0007
405 RHINORRHOEA 46 0.0007
406 MUSCULOSKELETAL CHEST PAIN 11 0.0007
407 SKIN REACTION 10 0.0007
408 PAIN IN JAW 20 0.0007
409 CIRCULATORY COLLAPSE 12 0.0007
410 DRUG INTOLERANCE 68 0.0007
411 PRODUCT DOSE OMISSION ISSUE 207 0.0007
412 SUBDURAL HAEMATOMA 10 0.0007
413 INFUSION SITE PAIN 9 0.0007
414 MIDDLE INSOMNIA 13 0.0007
415 EXERCISE TOLERANCE DECREASED 4 0.0007
416 RALES 4 0.0007
417 C-REACTIVE PROTEIN INCREASED 25 0.0007
418 HYPOVOLAEMIA 4 0.0007
419 SLEEP APNOEA SYNDROME 13 0.0007
420 LEUKOPENIA 34 0.0007
421 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
422 PRODUCT QUALITY ISSUE 92 0.0007
423 SINUS HEADACHE 4 0.0007
424 HYPERLIPIDAEMIA 8 0.0007
425 TRANSFUSION 7 0.0007
426 SKIN FISSURES 13 0.0007
427 NASAL CONGESTION 39 0.0007
428 PERIPHERAL SWELLING 102 0.0007
429 RENAL PAIN 7 0.0007
430 INGUINAL HERNIA 4 0.0007
431 HYPONATRAEMIA 37 0.0007
432 HEART RATE DECREASED 23 0.0007
433 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
434 CONSTIPATION 142 0.0007
435 SKIN CANCER 14 0.0006
436 HOT FLUSH 49 0.0006
437 PIGMENTATION DISORDER 4 0.0006
438 ORAL DISCOMFORT 9 0.0006
439 FAECES DISCOLOURED 14 0.0006
440 RASH 281 0.0006
441 SKIN EXFOLIATION 54 0.0006
442 MULTIPLE ALLERGIES 5 0.0006
443 FATIGUE 496 0.0006
444 SPINAL DISORDER 6 0.0006
445 SPUTUM DISCOLOURED 6 0.0006
446 SPEECH DISORDER 33 0.0006
447 DRY MOUTH 51 0.0006
448 HEADACHE 393 0.0006
449 LIMB INJURY 17 0.0006
450 PYREXIA 216 0.0006
451 MYDRIASIS 8 0.0006
452 POLLAKIURIA 26 0.0006
453 LYMPHOCYTE COUNT DECREASED 11 0.0006
454 HIP FRACTURE 20 0.0006
455 ERUCTATION 12 0.0006
456 UNRESPONSIVE TO STIMULI 16 0.0006
457 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
458 VITAMIN D DEFICIENCY 6 0.0006
459 EPISTAXIS 46 0.0006
460 MICTURITION URGENCY 7 0.0006
461 DEAFNESS 16 0.0006
462 SARS-COV-2 TEST POSITIVE 8 0.0006
463 RESTLESS LEGS SYNDROME 11 0.0006
464 SPINAL COMPRESSION FRACTURE 5 0.0006
465 INABILITY TO AFFORD MEDICATION 6 0.0006
466 ELECTROLYTE IMBALANCE 7 0.0006
467 BLOOD PRESSURE DECREASED 40 0.0006
468 THERAPY INTERRUPTED 43 0.0006
469 THERAPY NON-RESPONDER 27 0.0006
470 URINARY RETENTION 20 0.0006
471 OFF LABEL USE 524 0.0006
472 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
473 COLITIS ISCHAEMIC 4 0.0006
474 COVID-19 PNEUMONIA 7 0.0006
475 EYELID PTOSIS 6 0.0006
476 ATAXIA 7 0.0006
477 SLUGGISHNESS 6 0.0006
478 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
479 MOBILITY DECREASED 42 0.0006
480 LIVER FUNCTION TEST ABNORMAL 17 0.0006
481 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
482 PERIPHERAL COLDNESS 8 0.0006
483 DYSSTASIA 17 0.0006
484 CARDIAC OPERATION 5 0.0006
485 BRONCHITIS 43 0.0006
486 THROAT IRRITATION 26 0.0006
487 EXPOSURE VIA SKIN CONTACT 15 0.0006
488 LYMPHOEDEMA 4 0.0006
489 DIVERTICULITIS 16 0.0006
490 FALL 192 0.0006
491 INCREASED APPETITE 11 0.0006
492 PETECHIAE 6 0.0006
493 DRUG INEFFECTIVE 756 0.0006
494 LETHARGY 33 0.0006
495 CYANOSIS 9 0.0006
496 DEVICE USE ISSUE 10 0.0006
497 DEFAECATION URGENCY 4 0.0006
498 BURNING SENSATION 40 0.0006
499 FLUID RETENTION 29 0.0006
500 BLOOD CALCIUM INCREASED 5 0.0006
501 MOUTH ULCERATION 12 0.0006
502 SCRATCH 6 0.0006
503 PAIN 349 0.0006
504 IMMUNOSUPPRESSION 5 0.0006
505 LYMPHOPENIA 8 0.0006
506 PURPURA 5 0.0006
507 EATING DISORDER 12 0.0006
508 METABOLIC ACIDOSIS 18 0.0006
509 ACCIDENTAL EXPOSURE TO PRODUCT 58 0.0006
510 BLOOD PRESSURE INCREASED 86 0.0006
511 BODY HEIGHT DECREASED 6 0.0006
512 GAIT DISTURBANCE 107 0.0006
513 DEHYDRATION 74 0.0006
514 BACK DISORDER 9 0.0006
515 OPTIC NEURITIS 5 0.0005
516 TREATMENT NONCOMPLIANCE 30 0.0005
517 GASTROINTESTINAL PAIN 6 0.0005
518 UROSEPSIS 5 0.0005
519 NERVE COMPRESSION 5 0.0005
520 BLOOD CHOLESTEROL INCREASED 25 0.0005
521 ORAL PAIN 12 0.0005
522 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
523 NEPHROPATHY TOXIC 6 0.0005
524 BLISTER 30 0.0005
525 PULMONARY HYPERTENSION 11 0.0005
526 ASTHENIA 198 0.0005
527 SCAB 6 0.0005
528 PRODUCT STORAGE ERROR 46 0.0005
529 DEVICE FAILURE 8 0.0005
530 SKIN DISCOLOURATION 24 0.0005
531 LIPASE INCREASED 4 0.0005
532 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
533 BALANCE DISORDER 45 0.0005
534 FOOD ALLERGY 4 0.0005
535 SINUS CONGESTION 7 0.0005
536 DYSURIA 19 0.0005
537 EYELID OEDEMA 6 0.0005
538 HAEMOGLOBIN DECREASED 53 0.0005
539 RASH MACULAR 18 0.0005
540 COUGH 144 0.0005
541 HAEMATEMESIS 13 0.0005
542 GINGIVAL BLEEDING 7 0.0005
543 HAEMORRHAGIC STROKE 4 0.0005
544 RENAL FAILURE 68 0.0005
545 DIZZINESS 255 0.0005
546 POOR QUALITY SLEEP 11 0.0005
547 BRAIN FOG 8 0.0005
548 RENAL TUBULAR NECROSIS 5 0.0005
549 SYNCOPE 51 0.0005
550 AFFECTIVE DISORDER 4 0.0005
551 BLOOD IRON DECREASED 6 0.0005
552 BLOOD PRESSURE ABNORMAL 10 0.0005
553 GOUT 9 0.0005
554 ATRIAL FLUTTER 4 0.0005
555 BLOOD POTASSIUM DECREASED 15 0.0005
556 BRAIN INJURY 5 0.0005
557 ADRENAL INSUFFICIENCY 6 0.0005
558 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
559 FLATULENCE 28 0.0005
560 BLOOD POTASSIUM INCREASED 8 0.0005
561 TOOTH ABSCESS 5 0.0005
562 GASTROINTESTINAL HAEMORRHAGE 41 0.0005
563 CONTUSION 47 0.0005
564 HICCUPS 4 0.0005
565 URINARY TRACT INFECTION 83 0.0005
566 HYPERCALCAEMIA 6 0.0005
567 HAIR DISORDER 4 0.0005
568 HEART RATE INCREASED 48 0.0005
569 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
570 PHOTOSENSITIVITY REACTION 8 0.0005
571 HAIR COLOUR CHANGES 6 0.0005
572 HYPERTENSION 102 0.0005
573 NEPHROLITHIASIS 22 0.0005
574 DISORIENTATION 19 0.0005
575 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
576 BLOOD UREA INCREASED 8 0.0005
577 BLOOD SODIUM DECREASED 9 0.0005
578 HEAD INJURY 15 0.0005
579 MUSCLE ATROPHY 6 0.0005
580 MEMORY IMPAIRMENT 65 0.0005
581 URINARY INCONTINENCE 14 0.0005
582 OSTEOARTHRITIS 20 0.0005
583 RENAL INJURY 14 0.0005
584 CYSTITIS 15 0.0005
585 PULMONARY OEDEMA 21 0.0005
586 ERECTILE DYSFUNCTION 12 0.0005
587 PANIC ATTACK 17 0.0005
588 HAEMOPTYSIS 13 0.0005
589 DECREASED APPETITE 108 0.0005
590 HYPOACUSIS 20 0.0005
591 ATRIAL FIBRILLATION 45 0.0005
592 DELIRIUM 16 0.0005
593 SKIN SWELLING 4 0.0005
594 ORTHOSTATIC HYPOTENSION 8 0.0005
595 NERVOUSNESS 24 0.0005
596 PRODUCT PRESCRIBING ISSUE 10 0.0005
597 CELLULITIS 23 0.0005
598 SINUS DISORDER 9 0.0005
599 MELAENA 10 0.0005
600 LIMB DISCOMFORT 14 0.0005
601 DYSPNOEA 256 0.0005
602 COGNITIVE DISORDER 21 0.0004
603 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
604 THERAPY PARTIAL RESPONDER 7 0.0004
605 BASAL CELL CARCINOMA 7 0.0004
606 PRODUCT PHYSICAL ISSUE 9 0.0004
607 BLOOD CALCIUM DECREASED 5 0.0004
608 PRODUCT TASTE ABNORMAL 6 0.0004
609 RESPIRATORY TRACT CONGESTION 7 0.0004
610 MOOD ALTERED 12 0.0004
611 EXOSTOSIS 4 0.0004
612 INTERNAL HAEMORRHAGE 5 0.0004
613 CORONARY ARTERY OCCLUSION 6 0.0004
614 INCREASED TENDENCY TO BRUISE 4 0.0004
615 MUSCLE TWITCHING 10 0.0004
616 AGRANULOCYTOSIS 8 0.0004
617 SWELLING FACE 28 0.0004
618 NECK PAIN 24 0.0004
619 MASS 6 0.0004
620 BACTERIAL INFECTION 8 0.0004
621 NEPHROPATHY 4 0.0004
622 CARPAL TUNNEL SYNDROME 6 0.0004
623 SPINAL PAIN 5 0.0004
624 SURGERY 25 0.0004
625 PNEUMONIA 138 0.0004
626 DISCOMFORT 26 0.0004
627 MUSCLE SPASMS 78 0.0004
628 LEUKAEMIA 4 0.0004
629 DIALYSIS 6 0.0004
630 LIP SWELLING 14 0.0004
631 ANHEDONIA 11 0.0004
632 FACE OEDEMA 7 0.0004
633 PRODUCT DOSE OMISSION 27 0.0004
634 EAR INFECTION 11 0.0004
635 DIZZINESS POSTURAL 4 0.0004
636 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
637 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
638 PRESYNCOPE 10 0.0004
639 NEURALGIA 10 0.0004
640 GASTROENTERITIS 6 0.0004
641 AUTOIMMUNE DISORDER 4 0.0004
642 HAEMORRHOIDS 8 0.0004
643 ORAL HERPES 8 0.0004
644 DRUG INTERACTION 65 0.0004
645 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
646 BACK PAIN 95 0.0004
647 PHARYNGEAL SWELLING 4 0.0004
648 DYSPEPSIA 40 0.0004
649 SMALL INTESTINAL OBSTRUCTION 5 0.0004
650 CARDIOMYOPATHY 6 0.0004
651 OEDEMA 22 0.0004
652 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
653 NIGHT SWEATS 13 0.0004
654 CYST 5 0.0004
655 RESPIRATORY DISORDER 12 0.0004
656 DYSPHAGIA 38 0.0004
657 CHEST PAIN 74 0.0004
658 HEART RATE IRREGULAR 9 0.0004
659 PRURITUS 153 0.0004
660 DRY SKIN 53 0.0004
661 PRODUCT COMPLAINT 10 0.0004
662 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 28 0.0004
663 WOUND 11 0.0004
664 BODY TEMPERATURE INCREASED 8 0.0004
665 OXYGEN SATURATION DECREASED 22 0.0004
666 HYPOKALAEMIA 18 0.0004
667 INCORRECT DOSE ADMINISTERED 89 0.0004
668 EAR DISCOMFORT 4 0.0004
669 THERAPY CESSATION 20 0.0004
670 NEUROPATHY PERIPHERAL 37 0.0004
671 FEMUR FRACTURE 12 0.0004
672 MUSCULAR WEAKNESS 44 0.0004
673 POOR VENOUS ACCESS 4 0.0004
674 HIATUS HERNIA 5 0.0004
675 TENDERNESS 4 0.0004
676 PRODUCT ODOUR ABNORMAL 4 0.0004
677 JOINT STIFFNESS 10 0.0004
678 BEDRIDDEN 5 0.0004
679 ORAL CANDIDIASIS 5 0.0004
680 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 27 0.0004
681 IMMUNE SYSTEM DISORDER 5 0.0004
682 TOOTH INFECTION 5 0.0004
683 PULMONARY CONGESTION 5 0.0004
684 DISEASE RECURRENCE 18 0.0004
685 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
686 INFLUENZA 42 0.0004
687 DIARRHOEA 242 0.0004
688 DIABETIC KETOACIDOSIS 9 0.0004
689 JOINT INJURY 8 0.0004
690 HYPOTENSION 75 0.0004
691 SENSORY DISTURBANCE 6 0.0004
692 CARDIAC FAILURE CONGESTIVE 30 0.0004
693 JOINT RANGE OF MOTION DECREASED 5 0.0004
694 PSYCHOTIC DISORDER 11 0.0004
695 WHEEZING 22 0.0004
696 DECREASED ACTIVITY 4 0.0004
697 MUSCLE TIGHTNESS 6 0.0004
698 ERYTHEMA 76 0.0004
699 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
700 DYSKINESIA 15 0.0004
701 NASOPHARYNGITIS 68 0.0004
702 ILLNESS 38 0.0004
703 MUSCULOSKELETAL DISORDER 7 0.0004
704 FEELING JITTERY 7 0.0004
705 PNEUMONITIS 10 0.0004
706 PRODUCT SUBSTITUTION ISSUE 21 0.0004
707 OSTEOPOROSIS 15 0.0004
708 POST PROCEDURAL COMPLICATION 7 0.0004
709 JOINT SWELLING 44 0.0004
710 INJECTION SITE REACTION 25 0.0004
711 CARDIAC FAILURE 29 0.0004
712 VIRAL INFECTION 12 0.0004
713 TOOTH DISORDER 8 0.0004
714 NERVE INJURY 4 0.0004
715 HYPERTENSIVE CRISIS 4 0.0004
716 PLASMA CELL MYELOMA 14 0.0004
717 ABDOMINAL PAIN LOWER 9 0.0004
718 BLOOD TEST ABNORMAL 5 0.0004
719 HYPOAESTHESIA 53 0.0004
720 REBOUND EFFECT 4 0.0004
721 HAEMORRHAGE 37 0.0004
722 AMNESIA 23 0.0004
723 MYALGIA 60 0.0004
724 HYPOPHAGIA 9 0.0004
725 SINUSITIS 36 0.0004
726 RASH PRURITIC 19 0.0004
727 BRONCHOSPASM 5 0.0004
728 PARANOIA 6 0.0003
729 INFUSION RELATED REACTION 23 0.0003
730 PARAESTHESIA ORAL 5 0.0003
731 OROPHARYNGEAL PAIN 32 0.0003
732 EXTRA DOSE ADMINISTERED 14 0.0003
733 RESPIRATORY TRACT INFECTION 9 0.0003
734 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 70 0.0003
735 HYPOTHYROIDISM 11 0.0003
736 FLUID OVERLOAD 5 0.0003
737 RHEUMATOID ARTHRITIS 39 0.0003
738 MOVEMENT DISORDER 11 0.0003
739 NO ADVERSE EVENT 62 0.0003
740 ARTHROPATHY 19 0.0003
741 CHEST DISCOMFORT 35 0.0003
742 BONE PAIN 20 0.0003
743 PRODUCT USE ISSUE 64 0.0003
744 AGGRESSION 17 0.0003
745 LACTIC ACIDOSIS 11 0.0003
746 LIVER DISORDER 15 0.0003
747 BACTERAEMIA 4 0.0003
748 PRODUCT PRESCRIBING ERROR 8 0.0003
749 IMMUNODEFICIENCY 5 0.0003
750 MYOCLONUS 4 0.0003
751 FEAR 9 0.0003
752 MUSCLE RIGIDITY 4 0.0003
753 HYPOAESTHESIA ORAL 5 0.0003
754 TOOTHACHE 6 0.0003
755 INTENTIONAL PRODUCT MISUSE 29 0.0003
756 PALLOR 9 0.0003
757 PARAESTHESIA 52 0.0003
758 ECONOMIC PROBLEM 5 0.0003
759 BURSITIS 4 0.0003
760 PLATELET COUNT DECREASED 35 0.0003
761 INSURANCE ISSUE 5 0.0003
762 CYTOPENIA 4 0.0003
763 WEIGHT INCREASED 73 0.0003
764 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
765 DEVICE RELATED INFECTION 5 0.0003
766 MENTAL STATUS CHANGES 9 0.0003
767 SEPSIS 36 0.0003
768 HEPATIC STEATOSIS 6 0.0003
769 INSOMNIA 85 0.0003
770 HYPERHIDROSIS 41 0.0003
771 DERMATITIS ALLERGIC 4 0.0003
772 FRACTURE 6 0.0003
773 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
774 FOOT FRACTURE 6 0.0003
775 ALOPECIA 62 0.0003
776 OBESITY 5 0.0003
777 WHITE BLOOD CELL COUNT DECREASED 34 0.0003
778 BLOOD GLUCOSE DECREASED 15 0.0003
779 HYPOXIA 11 0.0003
780 LOSS OF CONSCIOUSNESS 40 0.0003
781 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
782 OEDEMA PERIPHERAL 38 0.0003
783 THROMBOSIS 25 0.0003
784 ARTHRALGIA 129 0.0003
785 CARDIAC DISORDER 29 0.0003
786 SKIN ULCER 8 0.0003
787 HAEMATOMA 8 0.0003
788 NODULE 4 0.0003
789 IMPAIRED HEALING 10 0.0003
790 DISABILITY 6 0.0003
791 DEPRESSED MOOD 16 0.0003
792 DIABETES MELLITUS 23 0.0003
793 ADVERSE REACTION 4 0.0003
794 TREMOR 50 0.0003
795 ABDOMINAL PAIN UPPER 62 0.0003
796 EXPIRED PRODUCT ADMINISTERED 10 0.0003
797 RENAL DISORDER 14 0.0003
798 COAGULOPATHY 5 0.0003
799 FUNGAL INFECTION 10 0.0003
800 MALIGNANT MELANOMA 4 0.0003
801 PERICARDITIS 5 0.0003
802 ABDOMINAL DISTENSION 31 0.0003
803 THROAT TIGHTNESS 8 0.0003
804 MALAISE 128 0.0003
805 GYNAECOMASTIA 9 0.0003
806 UNEVALUABLE EVENT 22 0.0003
807 INFLAMMATION 15 0.0003
808 COLITIS 11 0.0003
809 CHILLS 34 0.0003
810 SWELLING 27 0.0003
811 HYPOMAGNESAEMIA 4 0.0003
812 HUNGER 4 0.0003
813 MUSCULOSKELETAL STIFFNESS 25 0.0003
814 HYPERKALAEMIA 10 0.0003
815 INFECTION 41 0.0003
816 ANXIETY 80 0.0003
817 THERAPEUTIC RESPONSE DECREASED 17 0.0003
818 LIVER FUNCTION TEST INCREASED 6 0.0003
819 CEREBRAL HAEMORRHAGE 10 0.0003
820 DEATH 239 0.0003
821 HYPERTHYROIDISM 4 0.0003
822 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
823 PRODUCT DISPENSING ERROR 6 0.0003
824 HYPERGLYCAEMIA 10 0.0003
825 BONE DISORDER 5 0.0003
826 RESTLESSNESS 10 0.0003
827 ANAEMIA 52 0.0003
828 AGITATION 20 0.0003
829 BLOOD GLUCOSE ABNORMAL 5 0.0003
830 SKIN HAEMORRHAGE 4 0.0003
831 SLEEP DISORDER 19 0.0003
832 COLON CANCER 4 0.0003
833 GLOSSODYNIA 6 0.0003
834 RASH PAPULAR 6 0.0003
835 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
836 HEPATIC CIRRHOSIS 5 0.0003
837 BLOOD URINE PRESENT 5 0.0003
838 GASTRIC ULCER 5 0.0003
839 PLEURAL EFFUSION 16 0.0003
840 HAEMATURIA 9 0.0003
841 DRUG DISPENSING ERROR 4 0.0003
842 RESPIRATORY FAILURE 19 0.0003
843 BLOOD CREATININE INCREASED 17 0.0003
844 SEIZURE 30 0.0003
845 DISTURBANCE IN ATTENTION 14 0.0003
846 NAUSEA 205 0.0003
847 TENDONITIS 4 0.0003
848 ASTHMA 29 0.0003
849 KIDNEY INFECTION 5 0.0003
850 FEELING ABNORMAL 61 0.0003
851 HOSPITALISATION 39 0.0003
852 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
853 PNEUMOTHORAX 4 0.0003
854 MOOD SWINGS 8 0.0003
855 PANCYTOPENIA 14 0.0003
856 SPINAL FRACTURE 5 0.0002
857 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
858 VOMITING 117 0.0002
859 TACHYCARDIA 22 0.0002
860 STOMATITIS 15 0.0002
861 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
862 ILL-DEFINED DISORDER 15 0.0002
863 DISEASE PROGRESSION 29 0.0002
864 BLOOD GLUCOSE INCREASED 46 0.0002
865 CHOLELITHIASIS 8 0.0002
866 STAPHYLOCOCCAL INFECTION 8 0.0002
867 THROMBOCYTOPENIA 27 0.0002
868 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
869 PNEUMONIA ASPIRATION 6 0.0002
870 SKIN IRRITATION 11 0.0002
871 INTESTINAL OBSTRUCTION 9 0.0002
872 ASCITES 7 0.0002
873 LABORATORY TEST ABNORMAL 7 0.0002
874 RETCHING 5 0.0002
875 IRRITABLE BOWEL SYNDROME 5 0.0002
876 UNDERDOSE 17 0.0002
877 PRURITUS GENERALISED 5 0.0002
878 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
879 MUSCULOSKELETAL PAIN 12 0.0002
880 EPILEPSY 7 0.0002
881 ABNORMAL BEHAVIOUR 9 0.0002
882 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
883 FEBRILE NEUTROPENIA 15 0.0002
884 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
885 RASH MACULO-PAPULAR 5 0.0002
886 LUNG DISORDER 11 0.0002
887 GASTROINTESTINAL DISORDER 20 0.0002
888 DEVICE ISSUE 20 0.0002
889 JAUNDICE 6 0.0002
890 BLOOD BILIRUBIN INCREASED 6 0.0002
891 CHROMATURIA 5 0.0002
892 LEUKOCYTOSIS 4 0.0002
893 SKIN LESION 6 0.0002
894 PERICARDIAL EFFUSION 5 0.0002
895 NEUTROPENIA 29 0.0002
896 HYPOCALCAEMIA 4 0.0002
897 PROTEINURIA 4 0.0002
898 NEOPLASM MALIGNANT 14 0.0002
899 SKIN BURNING SENSATION 15 0.0002
900 HERPES ZOSTER 12 0.0002
901 DERMATITIS ATOPIC 11 0.0002
902 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
903 LOWER LIMB FRACTURE 4 0.0002
904 PANCREATITIS 11 0.0002
905 TYPE 2 DIABETES MELLITUS 7 0.0002
906 PANCREATIC CARCINOMA 6 0.0002
907 MENTAL DISORDER 9 0.0002
908 MYOCARDIAL INFARCTION 36 0.0002
909 MENTAL IMPAIRMENT 5 0.0002
910 EAR PAIN 4 0.0002
911 DRUG DOSE OMISSION 34 0.0002
912 ABASIA 5 0.0002
913 APHASIA 6 0.0002
914 FLUSHING 20 0.0002
915 PRODUCT PREPARATION ERROR 4 0.0002
916 DRUG-INDUCED LIVER INJURY 6 0.0002
917 DERMATITIS 4 0.0002
918 HEPATIC ENZYME INCREASED 13 0.0002
919 KNEE ARTHROPLASTY 4 0.0002
920 ABDOMINAL PAIN 43 0.0002
921 DEVICE DISLOCATION 8 0.0002
922 RESPIRATORY DISTRESS 5 0.0002
923 INJECTION SITE PAIN 55 0.0002
924 RENAL IMPAIRMENT 15 0.0002
925 PANCREATITIS ACUTE 4 0.0002
926 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
927 ADVERSE EVENT 16 0.0002
928 EMOTIONAL DISTRESS 21 0.0002
929 NEOPLASM PROGRESSION 6 0.0002
930 LUNG NEOPLASM MALIGNANT 7 0.0002
931 ROAD TRAFFIC ACCIDENT 7 0.0002
932 MULTIPLE SCLEROSIS 8 0.0002
933 DRUG EFFECT INCOMPLETE 6 0.0002
934 FIBROMYALGIA 4 0.0002
935 EMOTIONAL DISORDER 5 0.0002
936 SEPTIC SHOCK 7 0.0002
937 BONE DENSITY DECREASED 5 0.0002
938 CARDIOVASCULAR DISORDER 4 0.0002
939 INJECTION SITE SWELLING 12 0.0002
940 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
941 RASH GENERALISED 4 0.0002
942 SUICIDAL IDEATION 14 0.0002
943 INJECTION SITE BRUISING 12 0.0002
944 IRRITABILITY 9 0.0001
945 INJECTION SITE PRURITUS 10 0.0001
946 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
947 PROCEDURAL PAIN 4 0.0001
948 TARDIVE DYSKINESIA 4 0.0001
949 LYMPHADENOPATHY 5 0.0001
950 ACUTE MYOCARDIAL INFARCTION 4 0.0001
951 INFLUENZA LIKE ILLNESS 11 0.0001
952 DYSARTHRIA 5 0.0001
953 HEPATIC FAILURE 4 0.0001
954 CORONARY ARTERY DISEASE 4 0.0001
955 SUICIDE ATTEMPT 8 0.0001
956 ACNE 10 0.0001
957 FEELING HOT 8 0.0001
958 EXPOSURE DURING PREGNANCY 8 0.0001
959 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
960 NERVOUS SYSTEM DISORDER 4 0.0001
961 DEVICE MALFUNCTION 9 0.0001
962 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
963 RASH ERYTHEMATOUS 6 0.0001
964 TOXICITY TO VARIOUS AGENTS 21 0.0001
965 PSORIASIS 16 0.0001
966 CARDIAC ARREST 10 0.0001
967 SKIN DISORDER 4 0.0001
968 GASTRIC DISORDER 4 0.0001
969 INJECTION SITE HAEMORRHAGE 9 0.0001
970 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
971 COMA 5 0.0001
972 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
973 NEUTROPHIL COUNT DECREASED 4 0.0001
974 INJECTION SITE ERYTHEMA 12 0.0001
975 CARDIO-RESPIRATORY ARREST 4 0.0001
976 URTICARIA 16 0.0001
977 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
978 DRUG EFFECT DECREASED 5 0.0001
979 DEVICE DIFFICULT TO USE 6 0.0001
980 ANAPHYLACTIC REACTION 5 0.0001
981 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
982 INJURY 6 0.0001
983 INTERSTITIAL LUNG DISEASE 4 0.0001
984 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
985 DRUG WITHDRAWAL SYNDROME 7 0.0001
986 OVERDOSE 17 0.0001
987 INTENTIONAL OVERDOSE 5 0.0001
988 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
989 BREAST CANCER 6 0.0001
990 DRUG DOSE OMISSION BY DEVICE 4 0.0001